Beyond Acne Vulgaris: Role of Cutibacterium Acnes in Atopic Dermatitis and Psoriasis

Main Article Content

Maxwell Green
Nadia Kashetsky
Aileen Feschuk
Howard Maibach


atopic dermatitis, acne, microbiome, psoriasis


1. Xu H, Li H. Acne, the Skin Microbiome, and Antibiotic Treatment. Am J Clin Dermatol. 2019;20; 335-344.

2. Dréno B, Dagnelie MA, Khammari A, Corvec S. The Skin Microbiome: A New Actor in Inflammatory Acne. Am J Clin Dermatol. 2020;21; 18-24.

3. Francuzik W, Franke K, Schumann RR, Heine G, Worm M. Propionibacterium acnes Abundance Correlates Inversely with Staphylococcus aureus: Data from Atopic Dermatitis Skin Microbiome. Acta Derm Venereol. 2018;98; 490-495.

4. Kitagawa H, Yamanaka K, Kakeda M, Inada H, Imai Y, Gabazza EC, et al. Propionibacterium acnes vaccination induces regulatory T cells and Th1 immune responses and improves mouse atopic dermatitis. Exp Dermatol. 2011;20; 157-158.

5. Wang Y, Kuo S, Shu M, Yu J, Huang S, Dai A, et al. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol. 2014;98; 411-424.